Alpha Tau Medical
Price & Volume
Stats
See moreOpen | $12.38 |
Previous Close | $11.92 |
Day Range | $12.25-$12.39 |
52W Range | $3-$14.11 |
Market Cap | $1B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.67 |
News
See moreYahoo Finance • 20 days ago
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center
Yahoo Finance • 2 months ago
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
Yahoo Finance • 2 months ago
Alpha Tau And Tolmar Form Strategic Collaboration In U.S. Prostate Cancer
Yahoo Finance • 3 months ago
Alpha Tau to Participate in May Investor Conferences
About
CEO | Mr. Uzi Sofer |
Address | Kiryat HaMada St. 5, Jerusalem, Israel, 9777605 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 121 |